Chancity

Chicago BioCapital Summit 2026

The summit brings academics, entrepreneurs, and startups together with investors, operators, and industry leaders.

Date
November 12, 2026
City
Chicago

TL;DR

  • The summit is scheduled for November 12, 2026, in Chicago.
  • It connects academics, entrepreneurs, and startups with investors, operators, and industry leaders.
  • The organizer says past summits have drawn more than 600 attendees, alongside an exhibition featuring over 100 academic entrepreneurs and early-stage companies.

Who you'll find in the room

Academics

The summit's stated audience includes academics.

Entrepreneurs

Entrepreneurs are among the groups the summit connects.

Startups

Startups are among the groups the summit connects.

Investors

Investors are part of the summit's stated audience.

Operators

Operators are part of the summit's stated audience.

Featured speakers

18 listed

Alexis Borisy

Co-Founder and Chairman · Curie.Bio

Martin Burke, PhD

May and Ving Lee Professor for Chemical Innovation, and Professor of Chemistry · University of Illinois Urbana-Champaign

Mark Michalski

Chief Information Officer · Deerfield

Matt Tremblay, PhD

Chief Executive Officer · Blackbird Laboratories

Ci Chu, PhD

Chief Discovery Officer · Xaira Therapeutics

Sasha Huhalov, PhD

Head, Search and Evaluation · Takeda

Lore Gruenbaum, PhD

Chief Scientific Officer · Blood Cancer United

Clay B. Thorp

General Partner · Hatteras Venture Partners

Shana Kelley

President, Bioengineering & Head · Biohub Chicago

Grace Zheng

Co-founder and CEO · PerturbAI

Jacob Johnson

Founder and Strategic Advisor · innovosource

Michael Carleton

Senior Scientific Director · The Mark Foundation for Cancer Research

Luiz Miguel Camargo, PhD

Head of Data Foundry and Small Molecule External Innovation · Eli Lilly

Nicola La Monica, PhD

Sr. Director Search & Evaluation · J&J Innovative Medicine

Doug E. Frantz, PhD

Vice Chancellor for Innovation and Chief Commercialization Officer · Washington University in St. Louis

Henry Gosebruch

Chief Executive Officer · Lakefront Biotherapeutics

Wendy Yajnik

Global Head Academic Partnerships and External Innovation · Novartis

Dushyant Pathak

Chief Executive Officer · Autobahn Labs, Inc.

Questions people ask

8 answered

Chicago BioCapital Summit 2026 is scheduled for November 12.

The organizer reports that past summits have drawn over 600 attendees; this figure is not specified as the 2026 attendance.

The 2026 summit is held in Chicago.

The stated audience includes academics, entrepreneurs, startups, investors, and operators.

It fits academic founders and early-stage biotech teams looking for capital or pharma partners, since speakers include search and evaluation heads from Takeda and J&J Innovative Medicine as well as Hatteras Venture Partners, and the Hall of Inventions showcases early-stage ventures from Midwest universities. Established companies seeking late-stage deals would find the attendee pool skewed toward early work, given its focus on connecting academics and startups with investors.

Attendees at biotech investor and partnering events usually wear business casual, such as slacks and a blazer or button-down, with founders and investors rarely in full suits.

The organizer says past events have drawn over 600 attendees and featured an exhibition with more than 100 academic entrepreneurs and early-stage companies.

The stated audience spans academics, entrepreneurs, startups, investors, and operators, with industry leaders also part of the summit's connections.

Related events

Find more events with this kind of reach.

We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.

Also listed in